Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

The participants were implanted with a pacemaker-like device, under the skin in the chest that stimulated their left vagus ...

Participants in clinic trial went from being unable to get out of bed to being productive and interacting with loved ones ...

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

In a groundbreaking Interview, Professor Raz Yirmiya discusses his innovative research at the intersection of inflammation ...

An international team of researchers conducted a clinical trial on 493 adults whose major depression hadn't previously ...

Providers, patients and even some federal judges say progress-based insurance denials harm patients at key moments of mental ...

Vagus nerve stimulation (VNS) shows a positive treatment effect and improved quality of life (QoL) among patients with ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Master Sgt. Matthew Livelsberger, a highly decorated Special Forces soldier, had three recent visits for mental health ...